Results 31 to 40 of about 3,337,856 (280)

The accuracy of severity assessment tools designed for community acquired pneumonia among elderly patients with hospital acquired pneumonia

Asian Journal of Medical Sciences, 2016
Background: Pneumonia severity assessment is an essential initial step in the evaluation of patients with community acquired pneumonia. Many validated severity assessment tools were designed for use in this setting.
Doha Rasheedy
doaj   +1 more source

Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study

Acta Médica Portuguesa, 2019
Introduction: Hospital-acquired pneumonia continues to be a frequent complication in the intensive care unit and an important cause of admission in the intensive care unit.
Rui Dias Costa, João Pedro Baptista, Ricardo Freitas, Paulo Jorge Martins   +3 more
doaj   +1 more source

How to diagnose, treat and prevent from hospital-acquired and ventilator-associated pneumonia?

Journal of Education, Health and Sport, 2023
Introduction and purpose: hospital-acquired pneumonia and ventilator-associated pneumonia are common risk factors for morbidity and mortality. They are difficult to diagnose and treat due to the large number of factors that may contribute to the ...
Rafał Babiak, Karolina Bajak, Paulina Czuchryta, Anastazja Domańska, Agnieszka Gawęda, Agata Grabek, Julia Rutkowska, Żaneta Rzęsa-Tokarczyk, Klaudia Skorek, Agnieszka Urbańczyk   +9 more
doaj   +1 more source

Gender differences in incidence and in-hospital outcomes of community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in Spain

, 2020
Aims: We aim to compare the incidence and in-hospital outcomes of communityacquired pneumonia (CAP), ventilator-associated pneumonia (VAP) and nonventilator hospital-acquired pneumonia (NV-HAP) according to gender.
López De Andrés, Ana Isabel, Zamorano León, José Javier, Carabantes Alarcón, David, Albaladejo Vicente, Romana, López Herrán, Marta, Miguel Díez, Javier De, Zichen, Ji, Hernández Barrera, Valentín, Jiménez García, Rodrigo   +8 more
core   +1 more source

Hospital management of community-acquired pneumonia in Malta [PDF]

, 2012
Community-acquired pneumonia (CAP) remains a common diagnosis requiring hospital admission and a leading cause of death worldwide. No local guideline is currently available for the management of CAP.
Mamo, Jonathan, Micallef, Josef, Callus, Roberta, Montefort, Stephen   +3 more
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

STARTING ANTIBIOTIC THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN REAL CLINICAL PRACTICE

Siberian Journal of Life Sciences and Agriculture, 2020
Background. To analyze the real clinical practice of appointment starting antibacterial therapy for patients with community-acquired pneumonia in the Department of Pulmonology of a multidisciplinary hospital and estimate its compliance with clinical ...
Dar’ya Olegovna Shabalina, Natal’ya Yur’evna Tsibul’skaya, Evgeniy Vyacheslavovich Kozlov, Evgeniy Ivanovich Khar’kov   +3 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Novelties in the treatment of community-acquired and hospital-acquired pneumonia

Barcelona Respiratory Network Reviews
Pneumonia remains a leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems due to hospitalizations and the demand for medical resources.
Matteo Bassetti, Silvia Dettori, Federica Briano, Laura Mezzogori   +3 more
doaj   +1 more source